F

Freenome

Blood-based multiomics cancer detection tests

Computational Biologist

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A PhD degree in computational biology, cancer biology, statistics, bioinformatics, or a related quantitative field is required.
  • Experience in NGS assay and pipeline development, including a demonstrated track record of implementing complex workflows for high-throughput NGS data processing, is required.
  • Strong quantitative reasoning and data analysis skills, with demonstrated ability to apply them effectively to relevant scientific problems, are required.
  • Strong computational and programming skills are required, including thorough experience with Python statistical packages such as NumPy, Matplotlib, and Pandas, or equivalents in other languages such as R.
  • Excellent oral and written communication skills to communicate with scientific and broader audiences are required.
  • Ability to work cross-functionally with computational and experimental scientists is required.

Responsibilities

  • Lead the analysis and interpretation of molecular and clinical data in the context of early cancer detection, serving as a thought leader on the Computational Science team.
  • Suggest research hypotheses and areas for potential computational model and assay improvement, then plan, scope, and execute associated research in partnership with a multidisciplinary team.
  • Develop bioinformatics pipelines for high-throughput NGS data processing and analysis.
  • In collaboration with wet lab scientists, rapidly characterize and iterate on experimental methods by providing real-time assessments of assay performance, quality control, and clinical and diagnostic utility.
  • Remain current with molecular techniques in oncology and collaborate with the larger team to bring forward the next generation of assays for early cancer detection.

Desired Qualifications

  • Expert knowledge of chromatin biology, liquid biopsy, DNA methylation, and their relevance in early cancer detection.
  • Extensive experience working with DNA methylation data for biomarker discovery research.
  • Experience developing, applying, and evaluating statistical and/or machine learning algorithms.

About the Company

Freenome

Blood-based multiomics cancer detection tests

Freenome develops non-invasive blood tests for early cancer detection using a multiomics approach that analyzes genomic and proteomic data from blood. The test works by measuring biomarkers in a blood sample and applying algorithms to estimate cancer risk or presence, with results shared with healthcare providers and researchers. It differentiates itself by combining multiple data types and pursuing large clinical trials and collaborations to validate the tests. The goal is to make early, non-invasive cancer screening a routine part of healthcare, expanding nationwide efforts, especially for colorectal cancer, to improve detection and patient outcomes.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Freenome

See more jobs